Cardiovascular Risk Factors: Comparison Between Rheumatoid Arthritis and General Population
DOI:
https://doi.org/10.24950/rspmi.802Keywords:
Arthritis Rheumatoid, Cardiovascular Diseases, Dyslipidemias, Hypertension, Risk FactorsAbstract
Introduction: We aimed to analyze the relation between the rheumatoid
arthritis disease diagnosis and the presence of cardiovascular risk
factors, their prevalence along the disease’s progression and to determine
which ones are the most prevalent in this population.
Material and Methods: We performed an analytical observational
case-control study, where controls were matched by the patient’s
gender and age. The cardiovascular risk factors were defined by validated
criteria. Independent samples t-student and Mann-Whitney
tests were used to compare rheumatoid arthritis patients and controls.
Related samples t-student and Wilcoxon tests were carried out
to compare patients in different disease stages. Furthermore, logistic
regression was also performed to determine the main predictors of
patients’ cardiovascular risk.
Results: From 109 patients and 218 healthy subjects (70.6% female;
average age: 53 years), HDL, LDL, triglycerides and Framingham
scale at patients’ diagnosis were significantly different from controls
(p < 0.01). Currently, diastolic blood pressure and glomerular filtration
rate from patients were different from controls (p < 0.05). Patients had
higher diastolic blood pressure, total cholesterol and LDL at diagnosis
than recently (p < 0.05) and lower HDL (p < 0.001). Finally, age, systolic
blood pressure, LDL and triglycerides were associated with a higher
cardiovascular risk (p < 0.05) while female gender, diastolic blood pressure
and total cholesterol were associated with lower cardiovascular
risk (p < 0.05).
Conclusion: Rheumatoid arthritis patients have a high-risk lipid profile
and high blood pressure at diagnosis, which provides an elevated cardiovascular
risk.
Downloads
References
Browning M. Rheumatoid arthritis: a primary care approach. J Am Acad Nurse Pract. 2001; 13: 399-408.
Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Ame J Managed Care. 2012; 18(: 295-302.
Rindfleisch J, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005; 72: 1037-46.
Alamanosa Y, Drosos A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005; 4: 130-6.
Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C, et al. 2010 Rheumatoid arthritis classification criteria: an American College of
Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69: 1580- 8.
Fransen J, Stucki G, van Riel P. Rheumatoid arthritis measures. Arthritis Rheum. 2003; 44: 214 –24.
Naranjo A, Sokka T, Descalzo M, Calvo-Alén J, Horslev-Petersen K, Luukkainen R, et al. Cardiovascular disease in patients with rheumatoid
arthritis: results from the QUEST-RA study. Arthritis Res Therap. 2008; 10: 1-10.
Zubieta J, Choi H, Sadatsafavi M, Etminan M, Esdaile J, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008; 59: 1690-7.
Monroy J, Amaya J, Espinosa-Serna J, Herrera-Díaz C, Anaya J, Rojas- Villarraga A. Cardiovascular disease in rheumatoid arthritis: A systematic literature review in Latin America. Arthritis. 2012; 2012: 1-17.
Torigoe D, Laurindo I. Artrite reumatóide e doenças cardiovasculares. Rev Brasil Reumatol. 2006; 46: 60-6.
Gorman J. Smoking and rheumatoid arthritis: Another reason to just say no. Arthritis Rheum. 2006; 54: 10-3.
Amaya J, Monroy J, Mantilla R, Tamayo R, Rojas-Villarraga A, Anaya J. Novel risk factors for cardiovascular disease in rheumatoid arthritis.
Immunol Res. 2013;56:267-86.
Soeiro A, Haddad M, Almeida M, Ruppert A, Serrano Jr C. Artrite reumatóide e doença cardiovascular: o que sabemos e o que podemos fazer pelo paciente na actualidade? Rev Port Cardiol. 2011; 31: 225-32.
Direcção-Geral da Saúde. Norma número 020/2011 - Hipertensão Arterial: definição e classificação. 28/09/2011, atualizada a 19/03/2013.
Lisboa: DGS; 2011.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III). JAMA. 2001;285:2486-97.
American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
WHO global database on body mass index (BMI) [acessed Nov 2015] Available from: http://www.who.int/bmi.
Direcção-Geral da Saúde. Norma número 005/2013 - Avaliação do risco Cardiovascular SCORE. 19/03/2013. Lisboa: DGS; 2013.
Gonzalez A, Kremers H, Crowson C, Ballman K, Roger V, Jacobsen S, et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis. 2008; 67: 64-9.
Sherine G. Heart disease and rheumatoid arthritis: understanding the risks. Ann Rheum Dis. 2010; 69(Suppl I): i61-i64.
Kitas G, Sherine G. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis. 2011; 70: 8-14.
Panoulas V, Metsios G, Pace A, John H, Treharne G, Banks M, et al. Hypertension in rheumatoid arthritis. Rheumatology. 2008; 47: 1286-98.
Santos M, Vinagre F, Silva C, Gil V, Fonseca J. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. Acta Reumatol Port. 2010; 35: 325-32.
Toms T, Panoulas V, Douglas K, Griffiths H, Sattar N, Smith J, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis. 2010; 69: 683-8.
Bisoendial R, Stroes E, Kastelein J, Tak P. Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins. Nat Rev Rheumatol. 2010; 6: 157-64.
Kaplan M. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2006; 18: 289-97.
Schoeman C. Cardiovascular disease and rheumatoid arthritis: an update. Curr Rheumatol Rep. 2012; 14: 455-62.
Symmons D, Sherine G. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011; 7: 399-08.
Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to coventional cardiovascular risk actions. Ann Rheum Dis. 2009; 68: 460-9.
Robertson J, Peters M, Mclnnes I, Sattar N. Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev
Rheumatol. 2013; 9: 513-23.
Myasoedova E, Crowson C, Kremers H, Roger V, Fitz-Gibbon P, Therneau T, et al. Lipid paradox in rheumatoid arthritis: the impact of
serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011; 70: 482-7.
Kaplan M. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol. 2009; 5: 208-17.
Greenberg J, Furer V, Farkouh M. Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol. 2012; 8: 13-21.
Kremers H, Nicola P, Crowson C, Ballman K, Gabriel S. Cardiovascular Death in Rheumatoid Arthritis. Arthritis Rheum. 2005; 52: 722-32.
Liang K, Kremers H, Crowson C, Snyder M, Therneau T, Roger V, et al. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009; 36: 2462-9.
Longo F, Miñarro D, Torre I, Rábago E, Ramón S, Mahou M, et al. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum. 2009; 61: 419-24.
Tomasson G, Aspelund T, Jonsson T, Valdimarsson H, Felson D, Gudnason V. Effect of rheumatoid factor on mortality and coronary heart
disease. Ann Rheum Dis. 2010; 69: 1649-54.
Willerson J, Ridker P. Inflammation as a cardiovascular risk factor. Circulation. 2004; 109: 2-10.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Medicina Interna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna